(Press-News.org) Ames, Iowa - An Iowa State University researcher searched for new genes that are turned on during infection in a type of mosquito that is not only a pest, but transmits disease-causing pathogens.
Lyric Bartholomay, assistant professor of entomology, along with colleagues from around the world, infected the common southern house mosquito (Culex quinquefasciatus) with various pathogens to see which mosquito genes are activated in response to the infection.
Bartholomay is the first author on the paper, "Pathogenomics of Culex quinquefasciatus and Meta-Analysis of Infection Responses to Diverse Pathogens," to be published in the Oct. 1 issue of the journal Science.
The southern house mosquito is the third of the three most important mosquito disease carriers to have its genome sequenced. The first was an African mosquito (Anopheles gambiae) that transmits malaria parasites. Malaria infects 250 to 500 million people each year and kills nearly one million people annually, mostly young children in sub-Saharan Africa. The second was a tropical mosquito (Aedes aegypti) that carries yellow and dengue fever viruses.
The southern house mosquito is common to many areas of the United States and around the world. It feeds on blood from birds, livestock and humans, and transmits a wide variety of deadly and debilitating human and veterinary pathogens. In addition to transmitting the West Nile virus, the mosquito can carry the St. Louis encephalitis and the microscopic roundworm that causes lymphatic filariasis - a debilitating tropical disease that affects up to 40 million people every year.
Bartholomay participated in cataloging the infection-response genes for Aedes aegypti in a manuscript published in 2007. She was chosen to be first author of the current Science paper because she has experience describing the immune responses in the northern house mosquito (Culex pipiens).
In the research, mosquitoes were infected with viruses, worms and bacteria. The genes of the mosquitoes were monitored to see which changed during the response to infection and therefore could ward off disease.
"What we're trying to do is broaden our understanding of infection response genes beyond those that we expect to be there," said Bartholomay.
"We took a two-pronged approach to understanding infection responses," she added. "First, we scoured the genome sequence looking for those immunity genes that the mosquitoes can use to respond to an infection.
Then, we looked at what genes comprise broad spectrum and specific immune responses.
"We then took it one step further and compared the infection responses in Culex quinquefasciatus to similar infections in Aedes aegypti and Anopheles gambiae."
Bartholomay noted that the functions of many of the genes revealed in this analysis are still unknown, but as more is discovered about the functions of the genes, it could provide the first steps to controlling mosquito-borne diseases.
Bartholomay also worked with colleagues to analyze the mosquito's genome, as reported in a companion paper that will also be published in the current issue of Science.
INFORMATION:
Iowa State University researcher examines mosquito gene for new disease response
2010-10-01
ELSE PRESS RELEASES FROM THIS DATE:
Short and long sleep in early pregnancy linked to high blood pressure in the third trimester
2010-10-01
DARIEN, IL – A study in the Oct. 1 issue of the journal Sleep found that getting too little or too much sleep in early pregnancy is associated with elevated blood pressure in the third trimester. The study suggests that improving prenatal sleep hygiene may provide important health benefits.
Results show that the mean systolic blood pressure in the third trimester was 114 mm Hg in women with a normal self-reported nightly sleep duration of nine hours in early pregnancy, 118.05 mm Hg in women who reported sleeping six hours or less per night, and 118.90 mm Hg in women ...
Is photoscreening the best way to catch 'lazy eye'?
2010-10-01
SAN FRANCISCO, CA– Amblyopia, known as "lazy eye," is a major cause of vision problems in children and a common cause of blindness in people aged 20 to 70 in developed countries. In amblyopia the person's stronger eye is favored and his/her weaker eye gradually loses visual power as a result. When the condition is detected and treated before age 7, more than 75 percent of children achieve 20/30 vision or better, the Amblyopia Treatment Study reports. But parents and teachers can easily miss this problem–especially in very young children. Pediatric ophthalmologists (Eye ...
Most suicidal adolescents receive follow-up care after ER visits
2010-10-01
SAN FRANCISCO – For suicidal adolescents, the emergency department (ED) is most often the chosen portal to mental health services. New research, presented Friday, Oct. 1, at the American Academy of Pediatrics (AAP) National Conference and Exhibition in San Francisco, looks at what happens to the 30 percent of suicidal adolescents who are discharged from the ED and whether they go on to access additional mental health services.
In "Predictors of Mental Health Follow up Among Adolescents with Suicidal Ideation After Emergency Department Discharge," researchers followed ...
New lung cancer research finds half of advanced lung cancer patients receive chemotherapy
2010-10-01
For the first time to date, research published in the October edition of the Journal of Thoracic Oncology (JTO) sought to determine the use of chemotherapy in a contemporary, diverse non-small cell lung cancer (NSCLC) population encompassing all patient ages. Prior population-based studies have shown that only 20 to 30 percent of advanced lung cancer patients receive chemotherapy treatment. These studies have previously relied on the Medicare-linked Surveillance, Epidemiology, and End Results (SEER) database, thus excluding the 30 to 35 percent of lung cancer patients younger ...
TRUST study data confirms safety and efficacy of erlotinib for advanced lung cancer
2010-10-01
Featured in the October edition of the Journal of Thoracic Oncology (JTO), data from The Tarceva Lung Cancer Survival Treatment (TRUST) confirms the safety and efficacy profile of erlotinib, a highly potent oral active, reversible inhibitor of epidermal growth factor receptor (EGFR) tyrosine-kinase (TK) activity in a large heterogeneous non-small cell lung cancer (NSCLC) population.
Erlotinib has been shown to significantly increase survival for patients with previously treated advanced NSCLC. Certain groups of patients with NSCLC, such as those with a particular type ...
Genetically altered trees, plants could help counter global warming
2010-10-01
Forests of genetically altered trees and other plants could sequester several billion tons of carbon from the atmosphere each year and so help ameliorate global warming, according to estimates published in the October issue of BioScience.
The study, by researchers at Lawrence Berkeley National Laboratory and Oak Ridge National Laboratory, outlines a variety of strategies for augmenting the processes that plants use to sequester carbon dioxide from the air and convert it into long-lived forms of carbon, first in vegetation and ultimately in soil.
Besides increasing the ...
Adjunctive rufinamide reduces refractory partial-onset seizures
2010-10-01
Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial-onset seizures (POS). Details of this study are now available online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.
Epilepsy affects up to 2% of the worldwide population according to the Centers for Disease Control and Prevention. More than half of these patients experience POS, or focal seizures, which are initiated ...
Researchers find no difference in drugs for macular degeneration
2010-10-01
(Boston) – Researchers from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have conducted a study that failed to show a difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD). The study, which appears currently on-line in Eye, is believed to be the first study to describe one-year outcomes of a prospective, double-masked, randomized clinical trial directly comparing bevacizumab to ranibizuamab. Last October, these same researchers published early, six month ...
Flow of empty calories into children's food supply must be reduced
2010-10-01
St. Louis, MO, October 1, 2010 – With over 23 million children and adolescents in the US overweight or obese, the risks for many chronic diseases continue to increase. An article in the October issue of the Journal of the American Dietetic Association examines the diets of American youth and finds some disturbing results.
"The epidemic of obesity among children and adolescents is now widely regarded as one of the most important public health problems in the US," commented Jill Reedy, PhD, MPH, RD, and Susan M. Krebs-Smith, PhD, MPH, RD, both of the Division of Cancer ...
ColorTonerExpert's Fall Sale offers $1 Flat-Rate Shipping for all its Remanufactured Ink Cartridges
2010-10-01
ColorTonerExpert.com is a known and reliable printer supplies store for remanufactured laser toner cartridges, ink cartridges, fuser kits, maintenance kit, and MICR toners. Aside from its wide selection of affordable products, ColorTonerExpert is also committed in providing the best customer service that every ColorTonerExpert shopper will need.
To further continue its mission of giving only the greatest and inexpensive printer consumables, ColorTonerExpert.com is currently having its biggest Fall Sale wherein every remanufactured ink cartridge that a customer buys ...